Journal of Dermatological Science
Volume 59, Issue 2 , Pages 129-135 , August 2010

Granzyme B is a novel interleukin-18 converting enzyme

  • Youichi Omoto

      Affiliations

    • Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • ,
  • Keiichi Yamanaka

      Affiliations

    • Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • ,
  • Kazuya Tokime

      Affiliations

    • Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • ,
  • Shigehisa Kitano

      Affiliations

    • Department of Hematology and Oncology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • ,
  • Masato Kakeda

      Affiliations

    • Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • ,
  • Tomoko Akeda

      Affiliations

    • Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • ,
  • Ichiro Kurokawa

      Affiliations

    • Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • ,
  • Esteban C. Gabazza

      Affiliations

    • Immunology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • ,
  • Hiroko Tsutsui

      Affiliations

    • Department of Microbiology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
    • ,
  • Naoyuki Katayama

      Affiliations

    • Department of Hematology and Oncology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • ,
  • Kiyofumi Yamanishi

      Affiliations

    • Dermatology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
    • ,
  • Kenji Nakanishi

      Affiliations

    • Department of Immunology & Medical Zoology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
    • ,
  • Hitoshi Mizutani

      Affiliations

    • Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 59 231 5422; fax: +81 59 231 5423.

Received 9 December 2009 ,Revised 28 April 2010 ,Accepted 14 May 2010.

References 

  1. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001;12:53–72
  2. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423–474
  3. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature. 1997;386:619–623
  4. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science. 1997;275:206–209
  5. Gaggero A, De Ambrosis A, Mezzanzanica D, Piazza T, Rubartelli A, Figini M, et al. A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing. Oncogene. 2004;23:7552–7560
  6. Omoto Y, Tokime K, Yamanaka K, Habe K, Morioka T, Kurokawa I, et al. Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J Immunol. 2006;177:8315–8319
  7. Harris JL, Peterson EP, Hudig D, Thornberry NA, Craik CS. Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem. 1998;273:27364–27373
  8. Waugh SM, Harris JL, Fletterick R, Craik CS. The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity. Nat Struct Biol. 2000;7:762–765
  9. Jenne DE, Tschopp J. Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev. 1988;103:53–71
  10. Berke G. Unlocking the secrets of CTL and NK cells. Immunol Today. 1995;16:343–346
  11. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol. 2002;2:735–747
  12. Froelich CJ, Hanna WL, Poirier GG, Duriez PJ, D’Amours D, Salvesen GS, et al. Granzyme B/perforin-mediated apoptosis of Jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragment. Biochem Biophys Res Commun. 1996;227:658–665
  13. Song Q, Lees-Miller SP, Kumar S, Zhang Z, Chan DW, Smith GC, et al. DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J. 1996;15:3238–3246
  14. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, Casciola-Rosen L. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity. 1998;8:451–460
  15. Duriez PJ, Shah GM. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol. 1997;75:337–349
  16. Graubert TA, Russell JH, Ley TJ. The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood. 1996;87:1232–1237
  17. Park HJ, Kim JE, Lee JY, Cho BK, Lee WJ, Kim T, et al. Increased expression of IL-18 in cutaneous graft-versus-host disease. Immunol Lett. 2004;95:57–61
  18. Yawalkar N, Schmid S, Braathen LR, Pichler WJ. Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis. Br J Dermatol. 2001;144:1133–1139
  19. Yawalkar N, Hunger RE, Buri C, Schmid S, Egli F, Brand CU, et al. A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis: spongiotic skin lesions in allergic contact dermatitis are highly infiltrated by T cells expressing perforin and granzyme B. Am J Pathol. 2001;158:803–808
  20. Muller S, Lory J, Corazza N, Griffiths GM, Z’Graggen K, Mazzucchelli L, et al. Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. Am J Pathol. 1998;152:261–268
  21. Leon AJ, Gomez E, Garrote JA, Bernardo D, Barrera A, Marcos JL, et al. High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediat Inflamm. 2009;2009:580450
  22. Homs S, Mansour H, Desvaux D, Diet C, Hazan M, Buchler M, et al. Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant. 2009;9:1230–1236
  23. Striz I, Krasna E, Honsova E, Lacha J, Petrickova K, Jaresova M, et al. Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol Lett. 2005;99:30–35
  24. Spaeny-Dekking EH, Hanna WL, Wolbink AM, Wever PC, Kummer AJ, Swaak AJ, et al. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol. 1998;160:3610–3616
  25. Poe M, Blake JT, Boulton DA, Gammon M, Sigal NH, Wu JK, et al. Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity. J Biol Chem. 1991;266:98–103
  26. Talanian RV, Dang LC, Ferenz CR, Hackett MC, Mankovich JA, Welch JP, et al. Stability and oligomeric equilibria of refolded interleukin-1beta converting enzyme. J Biol Chem. 1996;271:21853–21858
  27. Fynbo CH, Lorentsen RH, Etzerodt M, Thogersen HC, Holtet TL. Characterization of a recombinant granzyme B derivative as a “restriction” protease. Protein Expr Purif. 2005;39:209–218
  28. Yamin TT, Ayala JM, Miller DK. Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme. J Biol Chem. 1996;271:13273–13282
  29. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem. 1997;272:17907–17911
  30. Backes C, Kuentzer J, Lenhof HP, Comtesse N, Meese E. GraBCas: a bioinformatics tool for score-based prediction of Caspase- and Granzyme B-cleavage sites in protein sequences. Nucleic Acids Res. 2005;33:W208–W213
  31. Konishi H, Tsutsui H, Murakami T, Yumikura-Futatsugi S, Yamanaka K, Tanaka M, et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci USA. 2002;99:11340–11345
  32. Yamanaka K, Tanaka M, Tsutsui H, Kupper TS, Asahi K, Okamura H, et al. Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol. 2000;165:997–1003
  33. Yoshimoto T, Mizutani H, Tsutsui H, Noben-Trauth N, Yamanaka K, Tanaka M, et al. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol. 2000;1:132–137
  34. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med. 1991;174:821–825
  35. Mee JB, Alam Y, Groves RW. Human keratinocytes constitutively produce but do not process interleukin-18. Br J Dermatol. 2000;143:330–336
  36. Nguyen KD, Vanichsarn C, Nadeau KC. Increased cytotoxicity of CD4+ invariant NKT cells against CD4+CD25hiCD127lo/- regulatory T cells in allergic asthma. Eur J Immunol. 2008;38:2034–2045
  37. Reading PC, Whitney PG, Barr DP, Wojtasiak M, Mintern JD, Waithman J, et al. IL-18, but not IL-12, regulates NK cell activity following intranasal herpes simplex virus type 1 infection. J Immunol. 2007;179:3214–3221
  38. Hyodo Y, Matsui K, Hayashi N, Tsutsui H, Kashiwamura S, Yamauchi H, et al. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J Immunol. 1999;162:1662–1668
  39. Inachi S, Mizutani H, Shimizu M. Epidermal apoptotic cell death in erythema multiforme and Stevens–Johnson syndrome. Contribution of perforin-positive cell infiltration. Arch Dermatol. 1997;133:845–849
  40. Lauw FN, Simpson AJ, Hack CE, Prins JM, Wolbink AM, van Deventer SJ, et al. Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria. J Infect Dis. 2000;182:206–213
  41. Tak PP, Spaeny-Dekking L, Kraan MC, Breedveld FC, Froelich CJ, Hack CE. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin Exp Immunol. 1999;116:366–370
  42. Fujino M, Kawasaki M, Funeshima N, Kitazawa Y, Kosuga M, Okabe K, et al. CrmA gene expression protects mice against concanavalin-A-induced hepatitis by inhibiting IL-18 secretion and hepatocyte apoptosis. Gene Ther. 2003;10:1781–1790
  43. Miura Y, Thoburn CJ, Bright EC, Hess AD. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand. Biol Blood Marrow Transplant. 2004;10:156–170
  44. Oberbauer R. Biomarkers—a potential route for improved diagnosis and management of ongoing renal damage. Transplant Proc. 2008;40:S44–S47
  45. Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, et al. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Exp Hematol. 2009;37:1216–1229
  46. Darmon AJ, Ehrman N, Caputo A, Fujinaga J, Bleackley RC. The cytotoxic T cell proteinase granzyme B does not activate interleukin-1 beta-converting enzyme. J Biol Chem. 1994;269:32043–32046
  47. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257

PII: S0923-1811(10)00183-0

doi: 10.1016/j.jdermsci.2010.05.004

Journal of Dermatological Science
Volume 59, Issue 2 , Pages 129-135 , August 2010

Article Tools

* Image Usage & Resolution